What conservative care for knee OA actually involves

Conservative care is the established first-line treatment for early-to-moderate knee osteoarthritis — not a bureaucratic step to be cleared before 'real' treatment begins. For most patients it produces meaningful pain relief and functional improvement in its own right.

The four core components are:

• Structured physiotherapy — exercise prescription targeting quadriceps strength, joint stability, and range of motion
• Weight management — reducing load through the joint with each step
• Analgesia — paracetamol and topical or oral NSAIDs used appropriately
• Activity modification — pacing and adapting daily movement to protect the joint

Intra-articular injections — corticosteroids, hyaluronic acid, and platelet-rich plasma (PRP) — sit within this framework as adjuncts, supporting the exercise programme rather than replacing it.

Consistent engagement across all relevant elements for at least three months is generally expected before a surgical referral is clinically justified. Conservative care aims to reduce pain and preserve function; it does not reverse the underlying structural changes in the joint.

Signs that conservative management is no longer controlling symptoms

Recognising when conservative measures have reached their limit is not always straightforward, but certain patterns — when they persist despite doing everything right — suggest it is time for specialist input.

Pain that disrupts sleep is one of the clearest signals. Knee pain that regularly wakes you at night, or prevents you from settling, points to a level of joint irritation that analgesia and self-management are no longer containing.

Significant loss of walking distance is another. Primary-care literature cites an inability to walk approximately 400 metres as a meaningful functional threshold; patients who can no longer walk to the shops, reach the car park, or move around the house without stopping are describing the same reality in everyday terms.

Difficulty with routine movements — rising from a low chair, descending stairs, getting in and out of a car — compounds over time and often indicates that quadriceps load-bearing capacity has declined beyond what exercise alone can restore.

Inability to sustain work or necessary daily activities despite a genuine trial of conservative care is a further prompt to escalate.

It is worth noting that symptoms and X-ray findings do not always align. Some people function reasonably well with severe radiological changes; others are significantly disabled with more moderate imaging. A scan showing bone-on-bone contact matters, but it is the functional picture — not the image alone — that determines whether escalation is warranted.

Meniscal damage, where present, can accelerate cartilage loss and may bring this decision point forward earlier than the standard timeline would suggest.

What NICE guidance says about referral for specialist review

NICE Guideline NG226, published in October 2022, sets the governing standard for knee replacement referral in England. It defines a two-part test: referral is appropriate when joint symptoms — pain, stiffness, reduced function, or deformity — substantially affect quality of life, and when non-surgical management has been ineffective or unsuitable. Both conditions must apply; neither alone is sufficient.

A clinically important element of NG226 is its explicit no-exclusion rule. Patients must not be turned away from referral on the basis of age, sex, smoking status, comorbidities, or body weight. Anyone told they need to lose weight before a referral can even be considered may have received advice that is inconsistent with current NICE guidance — weight management is part of conservative care, not a gatekeeping criterion for access to specialist review.

The referral decision should rest on clinical assessment and shared decision-making. No single scoring tool — including the Oxford Knee Score — can substitute for that conversation, however useful such tools are as supporting information.

Two further points are worth noting. Arthroscopy and joint washout for global knee pain due to OA are classified as low-value procedures under both NICE and NHS commissioning pathways; referrals made on this basis will not be accepted. And certain presentations bypass the standard pathway entirely: suspected septic arthritis, signs of inflammatory arthritis, possible serious underlying pathology, or a previously replaced knee all warrant urgent direct referral to secondary care, not community triage.

The overarching principle is clear — the decision is clinical, collaborative, and cannot lawfully be restricted by age or BMI alone.

How the referral pathway typically works in practice

For most patients, the journey from first noticing that conservative care is no longer working to sitting with an orthopaedic consultant involves several distinct steps — and understanding them in advance makes the process less frustrating.

The sequence typically runs as follows. The GP is the first point of contact, giving initial advice on analgesia, exercise, and weight management, and making an onward referral to physiotherapy. After a structured physiotherapy programme has been completed (or if symptoms are already beyond what physiotherapy can adequately address), the patient is usually referred to a community MSK service or assessed by an Extended Scope Physiotherapist (ESP). This intermediate tier reviews symptom severity, applies patient-reported outcome tools — the Oxford Knee Score is commonly used — and works with the patient through decision aids before deciding whether a consultant orthopaedic referral is warranted.

Pre-referral imaging is a standard requirement. NHS commissioning pathways, including those operating across Devon, specify that a standing AP and lateral knee X-ray must accompany all arthroplasty referrals for patients aged 55 or over; without it, a referral is likely to be returned.

Each stage carries its own waiting time. GP to physio, physio to community MSK, community MSK to consultant — these can add up to many months in total. Patients whose symptoms are significantly impacting their quality of life while they wait should be aware that independent musculoskeletal services exist that assess and treat without NHS waiting times and without requiring a GP referral first; this option is worth discussing with a GP if delays are becoming problematic.

Injections as a bridge between conservative care and surgery

The injections introduced as adjuncts during conservative care — corticosteroids, hyaluronic acid, and PRP — can also serve a distinct purpose further along the pathway: for patients who have exhausted standard conservative measures but are not yet at the point of surgical discussion, or who wish to defer it, they form a practical middle tier.

At this stage the clinical objective shifts. Rather than managing flares within an active physiotherapy programme, the aim is to reduce pain sufficiently to preserve function and quality of life while the next step is considered. Hyaluronic acid viscosupplementation and platelet-rich plasma (PRP) are the options most commonly used for this bridging purpose; corticosteroids offer shorter-term relief and are generally less suited to a sustained strategy.

Patient selection requires care. These injections depend on residual joint space to be effective, and imaging is needed to confirm it. At end-stage disease with bone-on-bone contact, their benefit is substantially reduced, and surgical referral becomes the more appropriate conversation. PRP carries a growing evidence base, though it is better supported in early-to-moderate disease than in advanced OA; the optimal sequence of these treatments ahead of surgical referral has not been definitively established, which means clinical judgement — not a fixed protocol — guides the choice.

Injections at this tier extend the window before surgery; they do not substitute for specialist review when functional decline is significant or accelerating.

What a specialist knee assessment covers

Arriving at a specialist knee assessment can feel like a significant threshold — understanding what it involves makes the conversation more productive.

The consultation combines clinical history (duration, pattern, and character of symptoms), physical examination, review of functional scores such as the Oxford Knee Score, and appraisal of existing imaging. Where X-rays are available, a standing AP and lateral view gives the clearest picture of compartmental involvement; an MRI may be requested if cartilage detail or meniscal integrity needs closer assessment.

The central question is which surgical option, if any, is appropriate. Total knee replacement (TKR) replaces all weight-bearing surfaces and is the definitive option for end-stage, multi-compartmental disease. Unicompartmental knee arthroplasty (UKR) is a more limited resurfacing, suited to isolated compartmental involvement in appropriately selected patients. Neither is automatically recommended: the discussion weighs functional impact, patient goals, fitness for surgery, and realistic expectations.

One practical argument for not indefinitely deferring specialist review once conservative measures are exhausted is that advanced deformity increases surgical complexity — options tend to be broader when assessment takes place before structural change becomes severe.

Lincolnshire Knee accepts patients without referral at its Sleaford and Grantham clinics — book at lincolnshireknee.co.uk. For most patients, the value of specialist assessment lies not in leaving with a surgical plan, but in gaining a clear picture of where they stand and what remains available to them.